EXHIBIT 99.1

 

UTMD Reports Financial Performance for Third Quarter and Nine Months of Year 2020

 

Contact: Crystal Rios (801) 566-1200October 27, 2020 

 

Salt Lake City, Utah – For the third calendar quarter (3Q) and first nine months (9M) of 2020, Utah Medical Products, Inc. (Nasdaq: UTMD) reports financial results described by CEO Kevin Cornwell as follows,

“As stockholders know, the desire to preserve capacity for treating patients with COVID-19 led to suspending many hospital medical procedures.  As a result, UTMD began to experience lower demand for its specialty medical devices in March during 1Q 2020.  As the largest segment of UTMD’s revenues in recent years has been in gynecology procedures deemed “nonessential” such as tubal ligation and loop excision of the transformation zone, UTMD sales dropped precipitously in 2Q 2020.

 

My view is that comparisons of 3Q and 9M 2020 results with the same periods in the prior year represent the magnitude of a revenue hole that UTMD fell into caused by COVID-19 management policies, not a fundamental trend. The trend which may be of more interest and cause for optimism is a comparison of successive quarterly revenues during 2020.  In this report, in addition to comparing with the prior year’s same time periods, which identify the “COVID-19 hole”, UTMD also presents 2020 successive quarterly sales by channel and product group.  In summary, 3Q 2020 U.S. domestic sales substantially recovered from 2Q 2020.  Although sales outside the U.S. (OUS) have been slower to recover, they nevertheless were significantly higher in 3Q 2020 than in the dismal 2Q 2020. Unless governments again restrict medical care, we see the recovery trend continuing to be positive, so that 4Q 2020 is likely to be UTMD’s best revenue quarter of the year.”  

 

Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted.  

 

Summary of Financial Results

UTMD management believes that the presentation of sequential 2020 quarterly results provides meaningful supplemental information to both management and investors.  Keeping in mind that results for any given three month period in comparison with a previous three month period may not be indicative of comparative results for the year as a whole, the following table shows the percent changes in 2020 quarterly results compared to the same periods of time in 2019:

 

Revenues [USD denominated]

1Q

2Q

3Q

9M

U.S. domestic  (excluding OEM)

+ 14.5%

(29.1%)

(8.0%)

(  9.2%)

Canada domestic

(21.7%)

(62.9%)

( 5.6%)

(32.0%)

Ireland domestic

(26.2%)

(48.6%)

(18.1%)

(30.9%)

UK domestic

(11.2%)

(72.8%)

(34.4%)

(38.7%)

France domestic

(11.8%)

(72.1%)

(12.3%)

(32.6%)

Australia domestic

(  8.6%)

(43.0%)

(13.6%)

(22.0%)

Subtotal, Direct to End User:

+ 4.2%

(39.1%)

(11.1%)

(16.3%)

 

All Other OUS (Sales to Int’l Distributors)

 

(  5.2%)

 

(  4.5%)

 

(34.7%)

 

(15.6%)

U.S. OEM Sales

+ 0.7%

+ 9.5%

( 8.9%)

(  0.6%)

Worldwide Revenues

+ 1.6%

(25.8%)

(16.1%)

(14.0%)


The following information was filed by Utah Medical Products Inc (UTMD) on Tuesday, October 27, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Utah Medical Products Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Utah Medical Products Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account